An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation
Authors
Keywords
B cells, Lymphomas, Transcriptional control, Messenger RNA, Cell proliferation, Co-immunoprecipitation, Gene expression, Transcription factors
Journal
PLoS Pathogens
Volume 13, Issue 7, Pages e1006500
Publisher
Public Library of Science (PLoS)
Online
2017-07-25
DOI
10.1371/journal.ppat.1006500
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
- (2016) Jens S. Kalchschmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation
- (2016) Xindong Liu et al. Cell Reports
- EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation
- (2016) Yonggang Pei et al. PLoS Pathogens
- Human Viral Oncogenesis: A Cancer Hallmarks Analysis
- (2014) Enrique A. Mesri et al. Cell Host & Microbe
- LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
- (2014) Shi-Dong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Dynamic Expression of BCL6 in Murine Conventional Dendritic Cells during In Vivo Development and Activation
- (2014) Ting-ting Zhang et al. PLoS One
- EBV-positive diffuse large B-cell lymphoma of the elderly
- (2013) C. Y. Ok et al. BLOOD
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8
- (2013) Shuvomoy Banerjee et al. PLoS Pathogens
- Roles of BCL6 in normal and transformed germinal center B cells
- (2012) Katia Basso et al. IMMUNOLOGICAL REVIEWS
- A Hsp40 Chaperone Protein Interacts with and Modulates the Cellular Distribution of the Primase Protein of Human Cytomegalovirus
- (2012) Yonggang Pei et al. PLoS Pathogens
- E2F1 Mediated Apoptosis Induced by the DNA Damage Response Is Blocked by EBV Nuclear Antigen 3C in Lymphoblastoid Cells
- (2012) Abhik Saha et al. PLoS Pathogens
- Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC
- (2011) R. Nahar et al. BLOOD
- Epstein-Barr Virus-Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes
- (2011) A. Saha et al. CLINICAL CANCER RESEARCH
- Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma
- (2011) D Martín-Pérez et al. LEUKEMIA
- FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
- (2011) Shanshan Duan et al. NATURE
- Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4Aand p14ARFexpression
- (2011) Seiji Maruo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epstein-Barr Virus Nuclear Antigen 3C Facilitates G1-S Transition by Stabilizing and Enhancing the Function of Cyclin D1
- (2011) Abhik Saha et al. PLoS Pathogens
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
- (2010) Leandro C. Cerchietti et al. CANCER CELL
- B-lymphocyte biology
- (2010) Tomohiro Kurosaki IMMUNOLOGICAL REVIEWS
- EBNA3C Attenuates the Function of p53 through Interaction with Inhibitor of Growth Family Proteins 4 and 5
- (2010) A. Saha et al. JOURNAL OF VIROLOGY
- Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification
- (2010) Robert E. White et al. PLoS One
- Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells
- (2009) K. Basso et al. BLOOD
- The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
- (2009) W. Ci et al. BLOOD
- Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
- (2009) A. Saha et al. JOURNAL OF VIROLOGY
- PU.1 Can Recruit BCL6 to DNA To Repress Gene Expression in Germinal Center B Cells
- (2009) F. Wei et al. MOLECULAR AND CELLULAR BIOLOGY
- Early Events Associated with Infection of Epstein-Barr Virus Infection of Primary B-Cells
- (2009) Sabyasachi Halder et al. PLoS One
- BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
- (2009) M. Saito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epstein–Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities
- (2009) Fuming Yi et al. VIROLOGY
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
- (2008) L. C. Cerchietti et al. BLOOD
- Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein
- (2008) B. G. Bajaj et al. JOURNAL OF VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started